[NKTR] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
06-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 42.30%
YoY- 27.21%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 20,499 21,585 28,330 48,847 23,315 1,087,717 34,589 -8.34%
PBT -51,169 -158,968 -125,162 -79,856 -110,187 975,345 -59,772 -2.55%
Tax -47 100 357 144 -278 3,885 99 -
NP -51,122 -159,068 -125,519 -80,000 -109,909 971,460 -59,871 -2.59%
Tax Rate - - - - - -0.40% - -
Total Cost 71,621 180,653 153,849 128,847 133,224 116,257 94,460 -4.50%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -249.39 -736.94 -443.06 -163.78 -471.41 89.31 -173.09 6.27%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.27 -0.85 -0.69 -0.45 -0.63 5.67 -0.39 -5.94%
EPS Diluted -0.27 -0.85 -0.69 -0.45 -0.63 5.33 -0.39 -5.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.